Position in HCM
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$13,194
New position
Shares Held
882
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 54 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 4.875283446712018.ToString("F0")%
Shared 0.ToString("F0")%
None 95.12471655328798.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $12,857,221 across 26 Drug Manufacturers - Specialty & Generic names. HCM ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
21,559 | $2,548,489 | |
| 2 | VTRS |
Viatris Inc
|
184,938 | $2,498,512 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,066 | $1,721,314 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,163 | $1,282,615 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
38,245 | $1,151,939 | |
| 6 | HLN |
Haleon plc
|
111,815 | $1,119,268 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
27,029 | $893,849 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
38,173 | $792,471 |
All Filings in HCM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,194 | 882 | Shares | Sole | 2026-06-03 | |
| No filing history on record for this holder in this stock. | ||||||